A Meta-Analysis of PCSK9 Inhibitors Versus Statins for LDL Cholesterol Reduction and Cardiovascular Outcomes. Cardiology and Cardiovascular Medicine, v. 9, n. 6, p. 491–498, 5 Dec.2025.